IP Library Granted Patent US 7,893,284
Granted Patent B2
US 7,893,284 · App. 11/233,945 · Granted Feb 22, 2011

Oestrogen derivatives as inhibitors of steroid sulphatase

Assignee: Sterix Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,893,284
App. No.
11/233,945
Granted
Feb 22, 2011
Kind
B2
Abstract

The present invention provides a compound comprising a steroidal ring system and an optional group R 1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the D ring of the steroidal ring system is substituted by a group R 2 of the formula -L-R 3 , wherein L is an optional linker group and R 3 is selected from groups which are or which comprise one of a nitrite group, an alcohol, an ester, an ether, an amine and an alkene, provided that when R 3 is or comprises an alcohol, L is present; and wherein the A ring of the steroidal ring system is substituted at position 2 or 4 with a group R 4 , wherein R 4 is a hydrocarbyl group.

Claims (45)

1. A compound of the formula

wherein R 1 is group selected from any one of —OH, or a sulphamate group of the formula

wherein R 5 and R 6 are independently selected from H, alkyl, cycloalkyl, alkenyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyl or aryl optionally contains one or more hetero atoms or groups;

R 2 is a group of the formula -L-R 3 , wherein L is an optional C 1-10 alkylene group and R 3 is a nitrile group, or R 3 is:

(a) a group of the formula

—(R 7 ) n (CR 14 R 15 ) p R 8

wherein n is 0 or 1, p is from 0 to 5;

R 7 is selected from ═CH—, —O— and NR 13 ;

R 8 is —C≡N;

R 13 is selected from H and C 1-10 alkyl;

R 14 and R 15 are each independently selected from H and C 1-10 alkyl; or

(b) a group of the formula —(CR 14 R 15 ) p R 8 ,

wherein p is from 0 to 5,

R 8 is —C≡N,

R 14 and R 15 are each independently selected from H and C 1-10 alkyl; or

(c) a group of the formula —(CH2) p R 8 ,

wherein p is from 0 to 5,

R 8 is —C≡N; or

(d) a group of the formula —(R 7 ) n R 8

wherein n is 0 or 1,

R 7 is selected from ═CH—, —O— and NR 13 ,

R 8 is —C≡N, and

R 13 is selected from H and C 1-10 alkyl;

wherein R 4 is an alkyl or alkoxy group.

2. A compound according to claim 1 wherein R 4 is methoxy.

3. A compound according to claim 1 wherein R 4 is ethyl.

4. A compound according to claim 1 wherein R 1 is —OH.

5. A compound according to claim 1 wherein R 1 is a sulphamate group.

6. A compound according to claim 5 wherein at least one of R 5 and R 6 is H.

7. A compound according to claim 6 wherein each of R 5 and R 6 is H.

8. A compound according to claim 1 wherein p is 0, 1 or 2.

9. A compound according to claim 1 wherein R 13 is —H.

10. A compound according to claim 1 wherein R 3 is a group selected from —CH 2 C≡N and ═CHC≡N.

11. A compound according to claim 1 wherein L is a C 1-5 alkylene, preferably C 1 or C 2 alkylene.

12. A compound according to claim 1 wherein R 2 is of the formula —R 3 .

13. A compound according to claim 1 wherein group R 2 is in an α conformation.

14. A compound according to claim 1 wherein R 1 is a sulphamate group and the compound is suitable for use as an inhibitor of oestrone sulphatase (E.C. 3.1.6.2).

15. A compound according to claim 14 wherein if the sulphamate group on the sulphamate compound were to be replaced with a sulphate group to form a sulphate compound then the sulphate compound would be hydrolysable by a steroid sulphatase enzyme (E.C.3.1.6.2).

16. A compound according to claim 14 wherein if the sulphamate group on the sulphamate compound were to be replaced with a sulphate group to form a sulphate compound and incubated with a steroid sulphatase enzyme (E.C.3.1.6.2) at a pH 7.4 and 37° C. it would provide a K m value of less than 50 mM.

17. A compound according to claim 14 wherein if the sulphamate group on the sulphamate compound were to be replaced with a sulphate group to form a sulphate compound and incubated with a steroid sulphatase enzyme (E.C.3.1.6.2) at a pH 7.4 and 37° C. it would provide a K m value of less than 50 μM.

18. A compound according to claim 1 of the following formula:

wherein R 4 , R 14 , R 15 and p are as defined in claim 1 .

19. A compound according to claim 1 wherein the compound is

20. A compound according to claim 1 wherein the compound is

21. A compound according to claim 1 wherein the compound is

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE SECOND INVENTOR'S NAME PREVIOUSLY RECORDED ON REEL 016969 FRAME 0526. ASSIGNOR(S) HEREBY CONFIRMS THE ALAN PUROHIT. Recorded Apr 20, 2010
From: LEESE, MATTHEW; PUROHIT, ATUL; REED, MICHAEL JOHN; CHANDER, SURINDER KUMAR; JOURDAN, FABRICE; POTTER, BARRY VICTOR LLOYD; NEWMAN, SIMON PAUL
To: STERIX LIMITED
Reel/Frame 024260/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2006
From: LEESE, MATTHEW; PUROHIT, ALAN; REED, MICHAEL JOHN; CHANDER, SURINDER KUMAR; JOURDAN, FABRICE; POTTER, BARRY VICTOR LLOYD; NEWMAN, SIMON PAUL
To: STERIX LIMITED
Reel/Frame 016969/0526 →
Continuity (2)
Continuation In Part PCTGB2004000705 · Feb 20, 2004
Related Publication 20060094696A1 · May 4, 2006